The science of biodefense: RNAi

Biosecurity and Bioterrorism

Volumn 5, Issue 2, 2007, Pages 104-106

  Chamberlain, Allison ^a   Grönvall, Gigi Kwik ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL WARFARE; HUMAN; PHYSIOLOGY; RNA INTERFERENCE; SHORT SURVEY; UNITED STATES;

BIOTERRORISM; HUMANS; RNA INTERFERENCE; UNITED STATES;

EID: 34547399576     PISSN: 15387135     EISSN: None     Source Type: Journal    
DOI: 10.1089/bsp.2007.0018     Document Type: Short Survey

References (12)

1. Sirna Therapeutics reports final results from phase 1 study on its RNAi-based therapeutic for age-related macular degeneration [press release]. San Francisco: Sirna Therapeutics; August 10, 2006. Available at: http://phx.corporate-ir.net/phoenix.zhtml?c=141787&p=irol- newsArticle&ID= 894673&highlight. Accessed May 2, 2007.
2. Ong SP, Choo BGH, Chu JJH, Ng ML. Expression of vector-based small interfering RNA against West Nile virus effectively inhibits virus replication. Antiviral Res 2006;72(3): 216-223.
3. Li B-j, Tang Q, Cheng D, et al. Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 2005;11(9):944-951.
4. Chang Z, Hu J. RNAi therapeutics: Can siRNAs conquer SARS? Gene Ther 2006;13(11):871-872.
5. Alnylam Pharmaceuticals. RSV therapeutic programs: respiratory syncytial virus. Available at: http://www.alnylam.com/therapeutic-programs/programs.asp. Accessed January 19, 2006.
6. Institute of Medicine. Globalization, Biosecurity and the Future of the Life Sciences. Washington, DC: Institute of Medicine; 2006.
7. United Kingdom. Scientific and technological developments relevant to the biological weapons convention. Paper presented at: Sixth Review Conference of the Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons (BTWC); November 2006; Geneva, Switzerland. Available at: http://www.unog.ch/ 80256EDD006B8954/(httpAssets)/5B93AF9D015AD633C12571FE0049ADAF/$ file/BWC-6RC-S&T-UK.pdf. Accessed May 2, 2007.
8. Nobel Prize in Physiology or Medicine 2006 [press release]. Stockholm, Sweden: The Nobel Foundation; October 2, 2006.
9. Merck & Co., Inc. to acquire Sirna Therapeutics, Inc. [press release]. Whitehouse Station, NJ, and San Francisco: Merck; October 30, 2006. Available at: http://www.merck.com/newsroom/press_releases/corporate/2006_1030. html. Accessed May 2, 2007.
10. Biotechnology Report 2006. Manchester, UK: Marks and Clerk; 2006.
11. Nurton J. Private sector lags behind in stem cell patenting. MIP Weekly News April 27, 2006. Available at: http://www. cpaglobal.com/static/ literature/files/644_mip_weekley_ news_(patent_analytics)_-_27_april_2006.pdf. Accessed May 2, 2007.
12. Fast-growing RNAi market shows no signs of slowing. Drug-Researcher. com August 11 2004. Available at: http://www. drugresearcher.com/news/ng. asp?id=55936-fast-growing-rnai. Accessed May 2, 2007.